Key Insights

Highlights

Success Rate

72% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

12.2%

5 terminated out of 41 trials

Success Rate

72.2%

-14.3% vs benchmark

Late-Stage Pipeline

10%

4 trials in Phase 3/4

Results Transparency

38%

5 of 13 completed with results

Key Signals

5 with results72% success

Data Visualizations

Phase Distribution

24Total
Not Applicable (10)
P 1 (2)
P 2 (8)
P 3 (3)
P 4 (1)

Trial Status

Completed13
Recruiting9
Unknown8
Terminated5
Active Not Recruiting3
Withdrawn2

Trial Success Rate

72.2%

Benchmark: 86.5%

Based on 13 completed trials

Clinical Trials (41)

Showing 20 of 20 trials
NCT06824402Not ApplicableRecruitingPrimary

Cryoprobe Biopsy and Chronic Rejection in Lung Transplant Recipients

NCT06082037Phase 3RecruitingPrimary

A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction

NCT07046910Phase 2RecruitingPrimary

Developing Hyperpolarized Gas MRI Signatures to Detect and Manage Acute Cellular Rejection

NCT03656926Phase 3Completed

Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)

NCT02812290RecruitingPrimary

Diagnostic and Therapeutic Applications of Microarrays in Lung Transplantation

NCT03657342Phase 3Completed

Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1)

NCT04941573TerminatedPrimary

Assessment of Chronic Lung Allograft Dysfunction Using Single-breath & Multi-breath Hyperpolarized Xenon-129 MRI

NCT05550662Phase 2TerminatedPrimary

HP 129Xe MRI for Evaluation of CLAD in Lung Transplant Recipients

NCT06399302Recruiting

Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes

NCT06309628TerminatedPrimary

Analysis of Volatile Organic Compounds in the Breath of Lung Transplant Rejection Patients Using Infrared Spectroscopy

NCT05170425Active Not RecruitingPrimary

LAMBDA 002 (Lung Registry) Study

NCT03967340Active Not RecruitingPrimary

PREdiction of Chronic LUng Allograft Dysfunction

NCT05501574Phase 2TerminatedPrimary

An Open Label Trial Evaluating the Safety, Tolerability, Efficacy and Pharmacokinetic Profile of Tacrolimus Inhalation Powder in Adult Lung Transplant Recipients

NCT05721079Not ApplicableCompleted

Extracorporeal Photopheresis (ECP) After Lung Transplantation

NCT06514378Phase 1Recruiting

Safety of Endobronchial Mesenchymal Stromal Cells in the Treatment of Chronic Lung Allograft Dysfunction

NCT06112951Not ApplicableRecruiting

A Prospective Randomized Trial of ECP in Subclinical AMR

NCT05006742Not ApplicableCompletedPrimary

Comparison of Transbronchial Cryobiopsy and Forceps Biopsy in Lung Transplant Recipients

NCT06302556Not Yet RecruitingPrimary

The Role of Immune Checkpoints in Lung Transplant (ILTRA)

NCT05526573Unknown

Diagnostic Yeld of Ultrathin Bronchoscopy in Peripheral Pulmonary Lesions

NCT06203964Active Not Recruiting

Organizing Pneumonia in Lung Transplant Recipients, a Restrospective Exploratory Study (OPIL-Study)

Scroll to load more

Research Network

Activity Timeline